Rani Therapeutics Holdings (RANI) Change in Acquisitions & Divestments (2022 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Change in Acquisitions & Divestments of $21.0 million for Q1 2026, little changed year-over-year from $21.0 million in Q1 2025, and up 265.22% quarter-over-quarter from $5.8 million in Q2 2025.
Rani Therapeutics Holdings (RANI) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $21.0 million for Q1 2026.
- In Q1 2026, Change in Acquisitions & Divestments changed 0.0% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $26.8 million (down 65.79% YoY), while the FY2025 annual figure was $26.8 million, down 65.51% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $21.0 million, up from $5.8 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $35.0 million in Q2 2023, with the low at $3.0 million in Q4 2022.
- The 5-year median for Change in Acquisitions & Divestments is $20.7 million (2024), against an average of $19.4 million.
- The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments jumped 661.67% in 2023, then sank 68.41% in 2025.
- Rani Therapeutics Holdings' Change in Acquisitions & Divestments stood at $3.0 million in 2022, then surged by 661.67% to $22.8 million in 2023, then retreated by 11.16% to $20.3 million in 2024, then sank by 71.67% to $5.8 million in 2025, then soared by 265.22% to $21.0 million in 2026.
- Business Quant data shows RANI's Change in Acquisitions & Divestments at $21.0 million in Q1 2026, $5.8 million in Q2 2025, and $21.0 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Rani Therapeutics Holdings | 163.98 Mn | 163.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.95 Mn |
| Jun 30, 2026 | 19.95 Mn |
| Mar 31, 2026 | 21.00 Mn |
| Mar 31, 2026 | 21.00 Mn |
| Jun 30, 2025 | 5.75 Mn |
| Jun 30, 2025 | 5.75 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Dec 31, 2024 | 20.30 Mn |
| Sep 30, 2024 | 18.70 Mn |
| Sep 30, 2024 | 18.70 Mn |
| Jun 30, 2024 | 18.20 Mn |
| Jun 30, 2024 | 18.20 Mn |
| Mar 31, 2024 | 20.35 Mn |
| Mar 31, 2024 | 20.35 Mn |
| Dec 31, 2023 | 22.85 Mn |
| Dec 31, 2023 | 22.85 Mn |
| Sep 30, 2023 | 23.50 Mn |
| Sep 30, 2023 | 23.50 Mn |